Prelude Capital Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Prelude Capital Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-103,298	Closed	-$2.2M	–	1574
2024 Q1	$2.2M	Buy	+103,298	New	+$1.24M	0.12%	214

Prelude Capital Management's FUSN Position: Q2 2024 in Review

Prelude Capital Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 103,298 shares — an estimated $2.2M sold.

Prelude Capital Management first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $2.2M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Prelude Capital Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Prelude Capital Management sold 103,298 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $2.2M.
Prelude Capital Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Prelude Capital Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $2.2M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.